270 related articles for article (PubMed ID: 30195774)
1. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
[TBL] [Abstract][Full Text] [Related]
2. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant).
Seyed Hosseini E; Nikkhah A; Sotudeh A; Alizadeh Zarei M; Izadpanah F; Nikzad H; Haddad Kashani H
Cancer Cell Int; 2021 Aug; 21(1):447. PubMed ID: 34425840
[TBL] [Abstract][Full Text] [Related]
3. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis.
Qian P; Xu Z; Chen H; Yue S; Lv Y
J Genet; 2020; 99():. PubMed ID: 32529986
[TBL] [Abstract][Full Text] [Related]
4. Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis.
Ma M; Han G; Wang Y; Zhao Z; Guan F; Li X
Aging (Albany NY); 2020 Dec; 13(2):2212-2230. PubMed ID: 33323540
[TBL] [Abstract][Full Text] [Related]
5. The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung
Wang J; Han X; Yuan Y; Gu H; Liao X; Jiang M
Front Genet; 2022; 13():821675. PubMed ID: 35450214
[No Abstract] [Full Text] [Related]
6. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
[No Abstract] [Full Text] [Related]
7. Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis.
Liu B; Peng Q; Wang YW; Qiu J; Zhu J; Ma R
Front Oncol; 2023; 13():1153076. PubMed ID: 37124526
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
[TBL] [Abstract][Full Text] [Related]
10. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
11. Development of a nine-lncRNA signature as a novel prognostic marker of estrogen receptor-negative breast cancer.
Wang Z; Wang J; Liu L; He Q; Wei M
Oncol Lett; 2020 Apr; 19(4):2979-2988. PubMed ID: 32218854
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.
Ma W; Chen X; Ding L; Ma J; Jing W; Lan T; Sattar H; Wei Y; Zhou F; Yuan Y
Oncotarget; 2017 Aug; 8(34):57755-57765. PubMed ID: 28915709
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.
Chen Q; Yang H; Zhu X; Xiong S; Chi H; Xu W
Front Genet; 2020; 11():566. PubMed ID: 32547604
[TBL] [Abstract][Full Text] [Related]
14. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
Su G; He Q; Wang J
Front Physiol; 2018; 9():652. PubMed ID: 29899709
[No Abstract] [Full Text] [Related]
15. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
17. Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
Yang X; Li J; Wang Y; Li P; Zhao Y; Duan W; Ariston Gabriel AN; Chen Y; Mao H; Wang Y; Du L; Wang C
Front Oncol; 2020; 10():515421. PubMed ID: 33194577
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Role of Long Non-Coding RNAs in Breast Cancer: a Systematic Review and Meta-Analysis.
Gao X; Xu J; Cao F; Chen F; Chen T; Li H; Deng Z; Xu S
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739040
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lncRNAs in lung carcinoma: a meta-analysis.
Fan F; Zhu Z; Gao C; Liu Y; Wang B; Wang Z; Feng J
Oncotarget; 2017 Oct; 8(47):83292-83305. PubMed ID: 29137343
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
